Intra Cellular Therapies | Zysk Brutto Na Sprzedaży

Gross Profit On Sales Zmiana Data
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Biogen USD 1.77B 102.7M 2023-12
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Marinus Pharmaceuticals USD 6.88M 1.19M 2023-09
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
RedHill Biopharma USD 990K 997K 2023-06
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12
Vanda Pharmaceuticals USD 42.56M 15.17M 2023-06



Intra Cellular Therapies Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2024.